Terumo Corp (OTCPK:TRUMY)
$ 19.951 0.281 (1.43%) Market Cap: 29.61 Bil Enterprise Value: 29.26 Bil PE Ratio: 37.79 PB Ratio: 3.39 GF Score: 97/100

Q2 2021 Terumo Corp Earnings Call Transcript

Nov 05, 2020 / 08:00AM GMT
Release Date Price: $19.79 (+3.03%)
Shinjiro Sato
Terumo Corporation - President, CEO & Director

Good evening. This is the CEO, Sato. My remarks will focus on the Alliance business, which is one area of effort in our growth strategy. Why? One, because we have received many questions about what will support Terumo's growth after COVID-19? Two, to this point, the state of the business has been somewhat hidden in the shadow of the Cardiac and Vascular business. Three, we have high expectations that the Alliance business will be a new growth driver going forward. Four, the business' performance has now grown to a size that merits some discussion. Five, it is also a new business model, which can be strategically applied to others. That's some of the background for why I will speak about the Alliance business.

Next slide, please. First, I will define what the Alliance business is within Terumo. In Terumo, the B2B business of supplying medical devices to and manufacturing on consignment for pharmaceutical companies is referred to as the Alliance business. Because it is related to providing pharmaceutical companies with core

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot